Medicare Enrolled

Dr. Melissa Lombardo, FNP

Nurse Practitioner - Family · Middletown, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
155 CRYSTAL RUN RD, Middletown, NY 10941
8457036999
In practice since 2015 (11 years)
NPI: 1396137618 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lombardo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lombardo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lombardo

Dr. Melissa Lombardo is a nurse practitioner - family in Middletown, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Lombardo performed 4,028 Medicare services across 1,643 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lombardo received a total of $2,704 from 21 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lombardo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 2% volume in NY $2,704 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,028
Medicare services
Top 2% in NY for nurse practitioner - family
1,643
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~366 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,800 $19 $24
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
465 $86 $145
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
242 $7 $8
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
207 $9 $10
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
170 $10 $11
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
158 $13 $14
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
139 $16 $17
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
136 $9 $9
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
108 $8 $8
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
86 $29 $30
Glutamyltransferase (GGT) level test
A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health.
74 $7 $7
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
73 $6 $6
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $63 $99
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
48 $10 $15
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
44 $40 $44
Urine microalbumin test
A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function.
43 $6 $7
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
43 $5 $12
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
39 $3 $4
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
23 $8 $8
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
20 $15 $15
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
19 $14 $16
Microsomal antibody test
A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system.
16 $14 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $111 $181
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
12 $75 $95
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,704
Total received (2021-2024)
Avg $676/year across 4 years
Top 10% in NY for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,704 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$954
2023
$658
2022
$601
2021
$491

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$292
Novo Nordisk Inc
$278
Abbott Laboratories
$155
Amgen Inc.
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Antares Pharma, Inc.
$25
Insulet Corporation
$24
RECORDATI_RARE_DISEASES_INC.
$21
Novartis Pharmaceuticals Corporation
$17
Top 3 companies account for 76.0% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,006
Lilly USA, LLC
$585
Abbott Laboratories
$293
Amgen Inc.
$218
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Antares Pharma, Inc.
$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Corcept Therapeutics
$43
Amarin Pharma Inc.
$37
AstraZeneca Pharmaceuticals LP
$33
Ultragenyx Pharmaceutical Inc.
$29
Medtronic, Inc.
$28
Insulet Corporation
$24
DEXCOM, INC.
$22
PFIZER INC.
$21
RECORDATI_RARE_DISEASES_INC.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Dexcom, Inc.
$19
Novartis Pharmaceuticals Corporation
$17
Tandem Diabetes Care, Inc.
$15
Hydrofera LLC
$11
Top 3 companies account for 69.7% of all-time payments
Associated products mentioned in payments ›
BAQSIMI · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FreeStyle Libre · GUARDIAN CONNECT · HYDROFERA BLUE · JARDIANCE · Korlym · LEQVIO · MOUNJARO · NOCDURNA · Omnipod · Otezla · Ozempic · PREVNAR 20 · RYBELSUS · Rybelsus · SIGNIFOR LAR · Saxenda · TRADJENTA · TRINTELLIX · TRULICITY · Vascepa · XIFAXAN · XYOSTED · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for nurse practitioner - family in NY.

Looking for a nurse practitioner - family in Middletown?
Compare family nurse practitioners in the Middletown area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
384
Per 100K population
95.1
County median income
$96,497
Nearest hospital
GARNET HEALTH MEDICAL CENTER
7.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lombardo is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with low-engagement industry engagement in the top 10% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lombardo experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lombardo performed 1,800 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lombardo receive payments from pharmaceutical companies?
Yes. Dr. Lombardo received a total of $2,704 from 21 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lombardo's costs compare to other family nurse practitioners in Middletown?
Dr. Lombardo's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lombardo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →